Send me a link:

*Text messaging rates may apply.

 Dow Down0.16% Nasdaq Up0.40%

More On DYAI



News & Info


Analyst Coverage



Dyadic International, Inc. (DYAI)

-Other OTC
1.54 Down 0.01(0.65%) Jul 23, 3:00PM EDT
ProfileGet Profile for:
Dyadic International, Inc.
140 Intracoastal Pointe Drive
Suite 404
Jupiter, FL 33477
United States - Map
Phone: 561-743-8333
Fax: 561-743-8343

Index Membership:N/A
Full Time Employees:39

Business Summary 

Dyadic International, Inc., a biotechnology company, discovers, develops, manufactures, and sells enzymes, proteins, peptides, and other bio-molecules for the bioenergy, biochemical, industrial enzyme, and biopharmaceutical industries. It primarily manufactures and sells liquid and dry enzyme products for use in the animal feed, pulp and paper, starch and alcohol, food and brewing, textiles, and bio fuels industries. The company utilizes an integrated technology platform based on its patented and proprietary C1 fungus technology, which enables the development and manufacture of various proteins and enzymes, as well as other biological products, such as antibodies, vaccines, proteins, and polypeptides for the biopharmaceutical industry. It also develops fungal strains that produce enzymes used in animal health and nutrition applications. The company has operations in the United States and the Netherlands. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Dyadic International, Inc.

Key Executives 
Mr. Mark A. Emalfarb , 59
Founder, Chairman, Chief Exec. officer, Pres and Chairman of Nominating Committee
Mr. Michael J. Faby ,
Chief Financial Officer and VP
Mr. Danai Brooks ,
Chief Operating Officer and Exec. VP
Mr. Thomas M. O'Shaughnessy ,
VP of Sales & Marketing
Mr. Richard H. Jundzil ,
VP of Operations
Amounts are as of Dec 31, 2006 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.